2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, směrnice pro lékařskou praxi, práce podpořená grantem
PubMed
34363988
DOI
10.1016/j.hrthm.2021.07.038
PII: S1547-5271(21)01916-0
Knihovny.cz E-zdroje
- Klíčová slova
- Ambulatory ECG monitoring, Antiarrhythmic drug therapy, Antitachycardia pacing, Arrhythmogenic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Asystole, Atrioventricular block, Bradycardia, Brugada syndrome, Cardiac channelopathies, Cardiac transplantation, Cardiomyopathy, Cardiovascular implantable electronic devices, Catecholaminergic polymorphic ventricular tachycardia, Children, Congenital heart disease, Coronary artery compression, ECG, Echocardiography, Endocardial lead, Epicardial lead, Expert consensus statement, Genetic arrhythmias, Heart block, Heart failure, Hypertrophic cardiomyopathy, Implantable cardioverter defibrillator, Insertable cardiac monitor, Lead extraction, Lead removal, Long QT syndrome, Low- and middle-income countries, MR imaging, Neuromuscular disease, PACES, Pacemaker, Pediatrics, Postoperative, Remote monitoring, Shared decision-making, Sick sinus syndrome, Sports and physical activity, Sudden cardiac arrest, Sudden cardiac death, Syncope, Transvenous, Ventricular fibrillation, Ventricular tachycardia,
- MeSH
- defibrilátory implantabilní * MeSH
- diagnostické techniky kardiovaskulární * MeSH
- diagnostické zobrazování MeSH
- dítě MeSH
- konsensus MeSH
- lidé MeSH
- odstranění implantátu MeSH
- srdeční elektrofyziologie normy MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- směrnice pro lékařskou praxi MeSH
- Geografické názvy
- Spojené státy americké MeSH
In view of the increasing complexity of both cardiovascular implantable electronic devices (CIEDs) and patients in the current era, practice guidelines, by necessity, have become increasingly specific. This document is an expert consensus statement that has been developed to update and further delineate indications and management of CIEDs in pediatric patients, defined as ≤21 years of age, and is intended to focus primarily on the indications for CIEDs in the setting of specific disease categories. The document also highlights variations between previously published adult and pediatric CIED recommendations and provides rationale for underlying important differences. The document addresses some of the deterrents to CIED access in low- and middle-income countries and strategies to circumvent them. The document sections were divided up and drafted by the writing committee members according to their expertise. The recommendations represent the consensus opinion of the entire writing committee, graded by class of recommendation and level of evidence. Several questions addressed in this document either do not lend themselves to clinical trials or are rare disease entities, and in these instances recommendations are based on consensus expert opinion. Furthermore, specific recommendations, even when supported by substantial data, do not replace the need for clinical judgment and patient-specific decision-making. The recommendations were opened for public comment to Pediatric and Congenital Electrophysiology Society (PACES) members and underwent external review by the scientific and clinical document committee of the Heart Rhythm Society (HRS), the science advisory and coordinating committee of the American Heart Association (AHA), the American College of Cardiology (ACC), and the Association for European Paediatric and Congenital Cardiology (AEPC). The document received endorsement by all the collaborators and the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS). This document is expected to provide support for clinicians and patients to allow for appropriate CIED use, appropriate CIED management, and appropriate CIED follow-up in pediatric patients.
Advocate Children's Heart Institute Chicago Illinois
Amrita Institute of Medical Sciences Kochi India
Bambino Gesù Children's Hospital IRCCS Rome Italy
Baylor College of Medicine Houston Texas
Bristol Royal Hospital for Children Bristol United Kingdom
Georg August University Medical Center Göttingen Germany
George Washington University Washington DC
Harvard Medical School Boston Massachusetts
Heart Centre Leipzig University of Leipzig Leipzig Germany
Inova Children's Hospital Fairfax Virginia
Mayo Clinic Rochester Minnesota
New York University Grossman School of Medicine New York New York
New York University Langone Health New York New York
Nicklaus Children's Hospital Miami Florida
Oregon Health and Science University Portland Oregon
Shizuoka General Hospital and Mt Fuji Shizuoka Children's Hospital Shizuoka Japan
St Luke's Health System Boise Idaho
Stanford University Palo Alto California
The Hospital for Sick Children Toronto Canada
University of Michigan Ann Arbor Michigan
University of Missouri Kansas City School of Medicine Kansas City Missouri
University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania
University of Southern California Keck School of Medicine Los Angeles California
University of Utah Health Sciences Center Salt Lake City Utah
University of Wisconsin School of Medicine and Public Health Madison Wisconsin
University Pediatricians Children's Hospital of Michigan Detroit Michigan
Vanderbilt University Medical Center Nashville Tennessee
Citace poskytuje Crossref.org
